BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3877767)

  • 1. Selective losses of large immune complexes during density gradient ultracentrifugation and an approach for prevention of these losses.
    Wener MH; Mannik M
    J Immunol Methods; 1985 Nov; 84(1-2):1-10. PubMed ID: 3877767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.
    Wener MH; Mannik M; Schwartz MM; Lewis EJ
    Medicine (Baltimore); 1987 Mar; 66(2):85-97. PubMed ID: 3102894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isopycnic ultracentrifugation of immune complexes.
    Rødahl E
    Scand J Immunol; 1985 Jan; 21(1):93-8. PubMed ID: 3969536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
    Jordon RE; Struve MF; Bushkell LL
    Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparative isolation of immune complexes from serum by sucrose gradient ultracentrifugation.
    Rødahl E; Iversen OJ; Dalen AB
    Scand J Immunol; 1984 Jul; 20(1):21-6. PubMed ID: 6463590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of immune complex lattice on the C1q solid phase assay as determined with covalently cross-linked immune complexes.
    Wener MH; Mannik M
    Clin Exp Immunol; 1983 Jun; 52(3):543-50. PubMed ID: 6603296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection of circulating immune complexes containing immunoglobulin G.
    Valentijn RM; van Es LA; Westedt ML; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):73-9. PubMed ID: 6748049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-mediated inhibition of immune precipitation. II. Analysis by sucrose density gradient ultracentrifugation.
    Schifferli JA; Peters DK
    Clin Exp Immunol; 1982 Mar; 47(3):563-9. PubMed ID: 6919473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
    Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
    J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability to activate complement is not required for the detection of immune complexes by the fluid-phase C1q binding assay.
    Fiocco GP; Davis JS; Burge JJ
    Arthritis Rheum; 1985 Feb; 28(2):222-5. PubMed ID: 3871617
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of immune precipitation by complement.
    Schifferli JA; Bartolotti SR; Peters DK
    Clin Exp Immunol; 1980 Nov; 42(2):387-94. PubMed ID: 6781802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
    Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
    Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and clinical significance of circulating immune complexes after renal transplantation.
    Fukuda M
    Transplantation; 1983 Aug; 36(2):155-60. PubMed ID: 6349040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of serum complement and rheumatoid factor on detection of immune complexes by the C1q and monoclonal rheumatoid factor solid-phase assay.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Immunol Methods; 1984 Oct; 73(2):301-11. PubMed ID: 6436384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new gradient former and a simplified procedure for zonal centrifugation of immune complexes.
    Steensgaard J; Jacobsen C
    J Immunol Methods; 1979; 29(2):173-83. PubMed ID: 479616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
    Antes U; Heinz HP; Loos M
    Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-antibody complexes produced in chickens tolerant to bovine serum albumin.
    Eardley DD; Tempelis CH
    J Immunol; 1975 Sep; 115(3):719-23. PubMed ID: 1151075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.